+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Traditional Chinese Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Traditional Chinese Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Traditional Chinese Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 208 Pages
  • July 2025
  • Region: China, Global
  • Fairfield Market Research
  • ID: 5918228
Description Jump to:
The global Traditional Chinese Medicine (TCM) market is projected to grow from US$ 30 billion in 2025 to US$ 44 billion by 2032, expanding at a robust compound annual growth rate (CAGR) of 5.62%. With increasing emphasis on preventive and integrative healthcare, TCM is gaining global recognition as a credible alternative to conventional treatments.

Market Insights

Traditional Chinese Medicine includes a broad spectrum of practices such as acupuncture, herbal medicine, tai chi, cupping, and moxibustion. These are rooted in ancient Chinese theories around the balance of yin and yang and the flow of “qi” (vital energy) through the body. In modern times, TCM is being increasingly adopted for the management of chronic conditions, stress-related ailments, neurological disorders, and pediatric behavioral issues.

Rising demand for plant-based therapeutics, supported by scientific research and clinical acceptance, is positioning TCM as a vital component of global wellness trends.

Key Market Drivers

  • Rising Behavioral and Chronic Health Conditions: The prevalence of ADHD, ASD, arthritis, anxiety, and sleep disorders has led to increased adoption of TCM solutions, particularly herbal formulations with neuroprotective and adaptogenic properties.
  • Affordability and Safety: Compared to pharmaceutical drugs, TCM is cost-effective and associated with fewer side effects, driving demand across all income segments.
  • Expanding Herbal Cultivation and R&D: Over 600 herbal production bases are being utilized to source medicinal plants such as Glycyrrhiza uralensis, Schisandra chinensis, and Panax ginseng, boosting innovation in herbal APIs.
  • Integration with Conventional Healthcare: Global recognition of acupuncture, herbal medicine, and massage therapy as complementary treatments is aiding mainstream adoption, particularly in hospitals and long-term care facilities.

Business Opportunity

Emerging economies across Asia Pacific and East Asia are experiencing surging demand for affordable TCM products due to local pharmaceutical expansion and rising health awareness. In developed regions, regulatory focus on product standardization and efficacy is creating demand for high-quality, clinically backed TCM formulations.

TCM also presents new opportunities in pediatric and geriatric care. In China, for example, nursing homes have significantly increased the integration of TCM services to support patient recovery and wellness.

Regional Analysis

  • United States: Leading the North American market, the U.S. is adopting TCM to address chronic disease management cost-effectively, with a strong preference for acupuncture and herbal therapies.
  • United Kingdom: With growing institutional support and practitioner regulation via the Association of Traditional Chinese Medicine and Acupuncture (ATCM), the U.K. market is steadily expanding.
  • China: As the epicenter of TCM tradition, China’s domestic and export markets are thriving. Increased use in eldercare institutions continues to support growth.

Key Players

Leading companies in the Traditional Chinese Medicine market are prioritizing innovation, manufacturing partnerships, and cross-border expansion. Strategic collaborations and research-driven product development remain central to their competitive approach.

Key market participants include:

  • Tongrentang
  • Zhongxin Pharmaceuticals
  • Tianjin Tasly Group
  • Yuannan Baiyao
  • Solstice Medicine Company, Inc.
  • Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
  • China Chinese Medicine Holding Co., Ltd.
  • Hunan Goldliloo Pharmaceutical Co., Ltd.
  • Wanbang Pharma Group Corp.
  • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline PLC
  • Mallinckrodt Pharmaceuticals
  • Hisamitsu Pharmaceutical Co., Inc.

Market Segmentation

By Product:

  • Traditional Chinese Medicine (TCM)
  • Autism Spectrum Disorder (ASD)
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Non-Traditional Chinese Medicine (Non-TCM)
  • Autism Spectrum Disorder (ASD)
  • Attention Deficit Hyperactivity Disorder (ADHD)

By Disease:

  • Autism Spectrum Disorder (ASD)
  • Attention Deficit Hyperactivity Disorder (ADHD)

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Traditional Chinese Medicine Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Traditional Chinese Medicine Market Outlook, 2019-2032
3.1. Global Traditional Chinese Medicine Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Traditional Chinese Medicine (TCM)
3.1.1.1.1. Autism Spectrum Disorder (ASD)
3.1.1.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
3.1.1.2. Non-Traditional Chinese Medicine (Non-TCM)
3.1.1.2.1. Autism Spectrum Disorder (ASD)
3.1.1.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
3.2. Global Traditional Chinese Medicine Market Outlook, by Disease, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Autism Spectrum Disorder (ASD)
3.2.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
3.3. Global Traditional Chinese Medicine Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Traditional Chinese Medicine Market Outlook, 2019-2032
4.1. North America Traditional Chinese Medicine Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Traditional Chinese Medicine (TCM)
4.1.1.1.1. Autism Spectrum Disorder (ASD)
4.1.1.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
4.1.1.2. Non-Traditional Chinese Medicine (Non-TCM)
4.1.1.2.1. Autism Spectrum Disorder (ASD)
4.1.1.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
4.2. North America Traditional Chinese Medicine Market Outlook, by Disease, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Autism Spectrum Disorder (ASD)
4.2.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Traditional Chinese Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. U.S. Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
4.3.1.2. U.S. Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
4.3.1.3. Canada Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
4.3.1.4. Canada Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Traditional Chinese Medicine Market Outlook, 2019-2032
5.1. Europe Traditional Chinese Medicine Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Traditional Chinese Medicine (TCM)
5.1.1.1.1. Autism Spectrum Disorder (ASD)
5.1.1.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.1.1.2. Non-Traditional Chinese Medicine (Non-TCM)
5.1.1.2.1. Autism Spectrum Disorder (ASD)
5.1.1.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.2. Europe Traditional Chinese Medicine Market Outlook, by Disease, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Autism Spectrum Disorder (ASD)
5.2.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Traditional Chinese Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Germany Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.2. Germany Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.1.3. U.K. Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.4. U.K. Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.1.5. France Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.6. France Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.1.7. Italy Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.8. Italy Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.1.9. Turkey Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.10. Turkey Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.1.11. Russia Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.12. Russia Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.1.13. Rest of Europe Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
5.3.1.14. Rest of Europe Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Traditional Chinese Medicine Market Outlook, 2019-2032
6.1. Asia Pacific Traditional Chinese Medicine Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Traditional Chinese Medicine (TCM)
6.1.1.1.1. Autism Spectrum Disorder (ASD)
6.1.1.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
6.1.1.2. Non-Traditional Chinese Medicine (Non-TCM)
6.1.1.2.1. Autism Spectrum Disorder (ASD)
6.1.1.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
6.2. Asia Pacific Traditional Chinese Medicine Market Outlook, by Disease, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Autism Spectrum Disorder (ASD)
6.2.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Traditional Chinese Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. China Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
6.3.1.2. China Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
6.3.1.3. Japan Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
6.3.1.4. Japan Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
6.3.1.5. South Korea Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
6.3.1.6. South Korea Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
6.3.1.7. India Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
6.3.1.8. India Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
6.3.1.9. Southeast Asia Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
6.3.1.10. Southeast Asia Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
6.3.1.11. Rest of Asia Pacific Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
6.3.1.12. Rest of Asia Pacific Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Traditional Chinese Medicine Market Outlook, 2019-2032
7.1. Latin America Traditional Chinese Medicine Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Traditional Chinese Medicine (TCM)
7.1.1.1.1. Autism Spectrum Disorder (ASD)
7.1.1.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
7.1.1.2. Non-Traditional Chinese Medicine (Non-TCM)
7.1.1.2.1. Autism Spectrum Disorder (ASD)
7.1.1.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
7.2. Latin America Traditional Chinese Medicine Market Outlook, by Disease, Value (US$ Bn), 2019-2032
7.2.1.1. Autism Spectrum Disorder (ASD)
7.2.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Traditional Chinese Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Brazil Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
7.3.1.2. Brazil Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
7.3.1.3. Mexico Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
7.3.1.4. Mexico Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
7.3.1.5. Argentina Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
7.3.1.6. Argentina Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
7.3.1.7. Rest of Latin America Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
7.3.1.8. Rest of Latin America Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Traditional Chinese Medicine Market Outlook, 2019-2032
8.1. Middle East & Africa Traditional Chinese Medicine Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Traditional Chinese Medicine (TCM)
8.1.1.1.1. Autism Spectrum Disorder (ASD)
8.1.1.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
8.1.1.2. Non-Traditional Chinese Medicine (Non-TCM)
8.1.1.2.1. Autism Spectrum Disorder (ASD)
8.1.1.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
8.2. Middle East & Africa Traditional Chinese Medicine Market Outlook, by Disease, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Autism Spectrum Disorder (ASD)
8.2.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Traditional Chinese Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. GCC Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
8.3.1.2. GCC Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
8.3.1.3. South Africa Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
8.3.1.4. South Africa Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
8.3.1.5. Egypt Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
8.3.1.6. Egypt Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
8.3.1.7. Nigeria Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
8.3.1.8. Nigeria Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
8.3.1.9. Rest of Middle East & Africa Traditional Chinese Medicine Market by Product, Value (US$ Bn), 2019-2032
8.3.1.10. Rest of Middle East & Africa Traditional Chinese Medicine Market by Disease, Value (US$ Bn), 2019-2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by Disease Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Zhongxin Pharmaceuticals
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Tianjin Tasly Group
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Yuannan Baiyao
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Solstice Medicine Company, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Shanghai Sundise Traditional Chinese Medicine Co., Ltd
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Chinese Medicine Holding Co., Ltd.
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Hunan goldliloo pharmaceutical Co., Ltd
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Wanbang Pharma Group Corp
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Pfizer Inc.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Eli Lilly and Company
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Tongrentang
  • Zhongxin Pharmaceuticals
  • Tianjin Tasly Group
  • Yuannan Baiyao
  • Solstice Medicine Company, Inc.
  • Shanghai Sundise Traditional Chinese Medicine Co., Ltd
  • China Chinese Medicine Holding Co., Ltd.
  • Hunan goldliloo pharmaceutical Co., Ltd
  • Wanbang Pharma Group Corp.
  • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline PLC
  • Mallinckrodt Pharmaceuticals
  • Hisamitsu Pharmaceutical Co., Inc.

Related Topics

Related Reports

Metabolic Disorders and Shen in Integrative Cardiovascular Chinese Medicine. Volume 7 - Product Image

Metabolic Disorders and Shen in Integrative Cardiovascular Chinese Medicine. Volume 7

  • Book
  • China
Mechanisms of Action in Disease and Recovery in Integrative Cardiovascular Chinese Medicine. Volume 6 - Product Image

Mechanisms of Action in Disease and Recovery in Integrative Cardiovascular Chinese Medicine. Volume 6

  • Book
  • China
Traditional Chinese Medicine Diagnostic Equipment Market by Product Type, Technology, End User, Application - Global Forecast to 2030 - Product Image

Traditional Chinese Medicine Diagnostic Equipment Market by Product Type, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 196 Pages
  • China, Global
From
Traditional Chinese Medicine Orientation Therapy Instrument Market by Product Type, Application, End User, Distribution Channel, Operation Mode, Price Range - Global Forecast to 2030 - Product Image

Traditional Chinese Medicine Orientation Therapy Instrument Market by Product Type, Application, End User, Distribution Channel, Operation Mode, Price Range - Global Forecast to 2030

  • Report
  • 194 Pages
  • China, Global
From
China - Traditional Chinese Medicine - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact - Product Image

China - Traditional Chinese Medicine - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact

  • Report
  • China
From

About the Traditional Chinese Medicine Market

Traditional Chinese Medicine (TCM) is a form of alternative and complementary medicine that has been practiced in China for thousands of years. It is based on the belief that the body has an energy system that can be balanced through the use of herbs, acupuncture, massage, and other treatments. TCM is used to treat a wide range of conditions, including pain, digestive issues, and mental health. It is also used to promote overall health and wellbeing. TCM is becoming increasingly popular in the West, with many people turning to it as an alternative to conventional medicine. It is seen as a holistic approach to health, focusing on the body as a whole rather than just treating individual symptoms. The TCM market is growing rapidly, with many companies offering products and services related to TCM. These include herbal supplements, acupuncture services, massage therapy, and traditional Chinese medicine practitioners. Some of the leading companies in the TCM market include Traditional Chinese Medicine Holdings, China Resources Pharmaceutical Group, and Beijing Tongrentang. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.